282 related articles for article (PubMed ID: 33495919)
21. Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis.
Yuhara H; Ogawa M; Kawaguchi Y; Igarashi M; Shimosegawa T; Mine T
J Gastroenterol; 2014 Mar; 49(3):388-99. PubMed ID: 23720090
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
[TBL] [Abstract][Full Text] [Related]
23. A Randomized Comparative Study of 24- and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Randomized Comparison Trial.
Kim SJ; Kang DH; Kim HW; Choi CW; Park SB; Song BJ; Nam HS
Pancreas; 2016 Sep; 45(8):1179-83. PubMed ID: 27253231
[TBL] [Abstract][Full Text] [Related]
24. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients.
Katoh T; Kawashima K; Fukuba N; Masuda S; Kobatake H; Masaki K; Araki Y; Kawano K; Nishi K; Takenaka M; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2020 Jul; 35(7):1247-1253. PubMed ID: 31788849
[TBL] [Abstract][Full Text] [Related]
25. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
26. Reduced risk of post ERCP pancreatitis in statin users.
Hadi YB; Naqvi SF; Abdelqader A; Kupec J; Nasr J
BMC Gastroenterol; 2020 Apr; 20(1):125. PubMed ID: 32326889
[TBL] [Abstract][Full Text] [Related]
27. Preventative Effect of Nafamostat Mesilate Infusion into the Main Pancreatic Duct on Post-ERCP Pancreatitis in a Porcine Model: Initial Pilot Study.
Park JS; Jeong S; Kim JM; Lee DH
J Invest Surg; 2020 Apr; 33(4):325-331. PubMed ID: 30884994
[No Abstract] [Full Text] [Related]
28. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
29. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
[TBL] [Abstract][Full Text] [Related]
30. Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post- endoscopic retrograde cholangiopancreatography pancreatitis.
Mukai S; Itoi T
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):709-22. PubMed ID: 26782710
[TBL] [Abstract][Full Text] [Related]
31. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
Pekgöz M
World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
[TBL] [Abstract][Full Text] [Related]
32. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Park SW; Yang MJ; Moon SH; Park DH
Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib Oral Administration for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized Prospective Trial.
Kato K; Shiba M; Kakiya Y; Maruyama H; Ominami M; Fukunaga S; Sugimori S; Nagami Y; Watanabe T; Tominaga K; Fujiwara Y
Pancreas; 2017 Aug; 46(7):880-886. PubMed ID: 28697127
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
[TBL] [Abstract][Full Text] [Related]
35. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
36. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
[TBL] [Abstract][Full Text] [Related]
37. Frequent guidewire passage into the pancreatic duct is an independent risk factor for postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) among high-risk individuals: A post-hoc analysis of a randomized controlled trial data.
Goenka MK; Akshintala VS; Kamal A; Bhullar FA; Bush N; Kumar V; Chakraborty M; Gurakar M; Lakhtakia S; Talukdar R; Trikudanathan G; Khashab MA; Kalloo AN; Reddy DN; Sinha SK; Singh VK; Kochhar R
J Dig Dis; 2023; 24(6-7):427-433. PubMed ID: 37505932
[TBL] [Abstract][Full Text] [Related]
38. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial.
Yoo KS; Huh KR; Kim YJ; Kim KO; Park CH; Hahn T; Park SH; Kim JH; Park CK; Kwon YJ; Lehman GA
Pancreas; 2011 Mar; 40(2):181-6. PubMed ID: 21206331
[TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
[TBL] [Abstract][Full Text] [Related]
40. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
Lua GW; Muthukaruppan R; Menon J
Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]